[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350543-105":3,"detail-sidebar-cat-0-en-105":80,"doc-detail-350543-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":73,"head_meta":75,"extra_data":77,"updated_unix":79},105,"en","the-application-of-nanomaterials-in-the-detection-of-liver-cancer-biomarkers-review","The Application of Nanomaterials in the Detection of Liver Cancer Biomarkers - Review","","Liver cancer has high global incidence and mortality, with hepatocellular carcinoma (HCC) forming about 90% of primary cases. Early-stage disease often lacks specific symptoms, so diagnosis is frequently delayed and patients are found at intermediate to advanced stages, leading to poor outcomes. Conventional methods show limited sensitivity and specificity. Nanomaterials offer promising physicochemical advantages, yet many studies remain laboratory-based and need large-scale clinical validation, which this review addresses.",{"@graph":14,"@context":72},[15,34,55],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-application-of-nanomaterials-in-the-detection-of-liver-cancer-biomarkers-review/350543/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-application-of-nanomaterials-in-the-detection-of-liver-cancer-biomarkers-review/350543.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":30},"InteractionCounter",{"@type":54},"ViewAction",{"@type":56,"mainEntity":57},"FAQPage",[58,64,68],{"name":59,"@type":60,"acceptedAnswer":61},"Why is early diagnosis of liver cancer critical?","Question",{"text":62,"@type":63},"Early-stage patients often lack specific symptoms, causing missed opportunities for curative treatment and resulting in poor prognoses. Earlier detection improves survival chances.","Answer",{"name":65,"@type":60,"acceptedAnswer":66},"What limitations affect conventional liver cancer diagnostics?",{"text":67,"@type":63},"Conventional methods often suffer from low sensitivity and insufficient specificity, and imaging modalities can have low sensitivity and risks related to contrast agent hypersensitivity.",{"name":69,"@type":60,"acceptedAnswer":70},"How do nanomaterials improve biomarker detection?",{"text":71,"@type":63},"Nanomaterials can enhance detection performance through mechanisms such as signal amplification, targeted recognition, and system optimization, leveraging properties like high surface-to-volume ratio and improved biocompatibility.","https://schema.org",{"og:url":32,"og:type":74,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":76,"canonical":32},"index,follow",{"doc_id":78,"site_id":7},350543,1792854867,{"code":4,"msg":81,"data":82},"success",[83,87,91,95,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":84,"show_sort_weight":85,"slug":86},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":88,"show_sort_weight":89,"slug":90},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":92,"show_sort_weight":93,"slug":94},"Exam",70,"exam",{"id":96,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},5,"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":96,"slug":129},19,"General","general",{"code":4,"msg":81,"data":131},{"doc_id":78,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":30,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","International Journal of Nanomedicine  \n Open Access Full Text Article  \nThe Application of Nanomaterials in the Detection of Liver Cancer Biomarkers  \nREVIEW  \nDianya Qiu*, Weihua Cao*, Yuanjiao Gao*, Tianyu Ma*, Wen Deng, Shiyu Wang, Yaqin Zhang, Xin Wei, Linmei Yao, Zixuan Gao, Shuojie Wang, Minghui Li   \nDepartment of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, Beijing, 100015, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Minghui Li, Department of Hepatology Division 2, Beijing Ditan Hospital, Capital Medical University, 8\\# Jing Shun East Street, Chaoyang District, Beijing, 100015, People’s Republic of China, Tel +86 13693259096, [Email wuhm2000@sina.com](Email wuhm2000@sina.com)  \n\n| Abstract: Liver cancer is one of the malignant tumors with high global incidence and mortality rates, with hepatocellular carcinoma (HCC) accounting for 90% of primary liver cancer cases. Due to the lack of specific symptoms in early-stage liver cancer, diagnosis is often delayed, leading to the majority of patients being identified at intermediate to advanced stages with poor prognoses. Early diagnosis is critical for improving patient survival; however, conventional diagnostic methods face limitations such as low sensitivity and insufficient specificity. Nanomaterials have demonstrated great potential in laboratory research to overcome the limitations of traditional detection technologies by virtue of their unique physicochemical properties. However, most of these relevant studies are still in the laboratory stage and require large-scale clinical validation. This review systematically summarizes the innovative applications of nanomaterials in liver cancer biomarker diagnostics, focusing on their mechanisms for improving detection performance, including signal amplification, targeted recognition, and system optimization. It highlights specific applications of nanomaterials in biomarker detection, discusses current challenges in nanodiagnostic technologies, and explores future development trends, aiming to provide novel perspectives for the diagnosis of liver cancer patients.\u003Cbr>Keywords: liver cancer, nanomaterials, nanoparticles, biomarkers, diagnosis, detection technologies |\n| --- |\n| Introduction\u003Cbr>The primary pathological types of primary liver cancer include hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular-cholangiocarcinoma, with HCC accounting for 90% of cases.1 Liver cancer remains one of the leading causes of cancer-related mortality worldwide. Epidemiological data indicate approximately 865,000 new liver cancer cases annually globally, representing over 4% of all cancer diagnoses, with 758,000 deaths annually (7.8% of total cancer deaths) . This positions liver cancer as the third most lethal malignancy after lung and colorectal cancers, and the second leading cause of cancer death among male patients.2 The high mortality rate of liver cancer is closely linked to challenges in early diagnosis. Early-stage liver cancer patients typically lack specific symptoms, which frequently leads to oversight. Most patients are diagnosed at intermediate to advanced stages, missing opportunities for curative treatment and resulting in poor prognoses. Consequently, early diagnosis is pivotal for improving survival rates.3\u003Cbr>Breakthroughs in nanotechnology and novel nanomaterial development have created vast prospects for nanomedicine in precision diagnostics and therapeutics. Nanomaterials exhibit advantages such as high surface-to-volume ratio, low toxicity, enhanced sensitivity, and biocompatibility.4–6 These unique physicochemical properties endow nanomaterials with the potential to break through the limitations of traditional detection technologies and improve detection performance under laboratory conditions; however, their clinical value in the detection of hepatocellular carcinoma biomarkers still needs to b","cbCaidxNGz7rReEW","https://ap.wps.com/l/cbCaidxNGz7rReEW","pdf",7755750,27,"English","# Abstract\n# Introduction","[{\"question\":\"Why is early diagnosis of liver cancer critical?\",\"answer\":\"Early-stage patients often lack specific symptoms, causing missed opportunities for curative treatment and resulting in poor prognoses. Earlier detection improves survival chances.\"},{\"question\":\"What limitations affect conventional liver cancer diagnostics?\",\"answer\":\"Conventional methods often suffer from low sensitivity and insufficient specificity, and imaging modalities can have low sensitivity and risks related to contrast agent hypersensitivity.\"},{\"question\":\"How do nanomaterials improve biomarker detection?\",\"answer\":\"Nanomaterials can enhance detection performance through mechanisms such as signal amplification, targeted recognition, and system optimization, leveraging properties like high surface-to-volume ratio and improved biocompatibility.\"}]","The Application of Nanomaterials in the Detection of Liver Cancer Biomarkers - Review | PDF",1790089508,68,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/108650f8d34bce9d286d5df41e9fd780.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c6bc90aebc7be1edc646869e10d4b440.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ae0b27969c4a0cb742dcb283b56fa73.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e0442ff0c638ab6ef83d64caebec9128.webp",980,1268]